Longevity PapersAbout
← All papers
RESEARCH PAPER / 2026-01-12

Pioneers: Glucose Sensing and Control of Health-span and Lifespan.

Sheng-Cai Lin

School of Life Sciences, Xiamen University, Fujian, China. Electronic address: [email protected]. · pubmed

Abstract

My independent career started based on a simple doctrine of protein multifunctionality, by intuitively choosing the protein called AXIN, which has turned out to be the protagonist of my scientific life. This led us to discover the sensing pathway for glucose, which links to AMPK and mTORC1, two master metabolic controllers. We found that AXIN binds LKB1, an upstream kinase of AMPK, and that the AXIN:LKB1 complex translocates to the lysosomal surface after the lysosomal aldolase senses low glucose (fructose-1,6-bisphosphate as the direct signal) to activate AMPK and concomitantly inhibit mTORC1. Remarkably, we found that the lysosomal glucose-sensing AMPK pathway is shared by metformin, a glucose-lowering drug known to also extend lifespan and reduce cancer risk. In search of metabolites enriched in calorie-restricted mice and able to activate AMPK via the lysosomal pathway, we identified that lithocholic acid (LCA) as such a factor. We also identified TULP3 as the LCA receptor, which signals to activate sirtuins, increase NAD

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper claims that the lysosomal glucose-sensing AMPK pathway, activated by lithocholic acid, plays a role in health-span and lifespan extension. This research is relevant as it explores metabolic pathways that could potentially address the root causes of aging and longevity.

Author of this paper? Send a correction.